BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 28471824)

  • 21. The actual management of early pancreatic cancer.
    Iglesias García J; Lariño-Noia J; Domínguez-Muñoz JE
    Minerva Gastroenterol Dietol; 2012 Dec; 58(4):321-30. PubMed ID: 23207609
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Pancreatic cancer- a curable disease].
    Limani P; Samaras P; Lesurtel M; Graf R; DeOliveira ML; Petrowsky H; Clavien PA
    Praxis (Bern 1994); 2015 Apr; 104(9):453-60. PubMed ID: 25900693
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Diagnosis and management of pancreatic cancer.
    De La Cruz MS; Young AP; Ruffin MT
    Am Fam Physician; 2014 Apr; 89(8):626-32. PubMed ID: 24784121
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diagnostic clues and subsequent examinations that detected small pancreatic cancer.
    Kawada N; Uehara H; Katayama K; Takakura R; Ioka T; Tanaka S; Takenaka A; Tomita Y; Ishikawa O
    Hepatogastroenterology; 2012 Sep; 59(118):1665-9. PubMed ID: 22591644
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Update on the management of pancreatic cancer: surgery is not enough.
    Ansari D; Gustafsson A; Andersson R
    World J Gastroenterol; 2015 Mar; 21(11):3157-65. PubMed ID: 25805920
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Increasing survival rates of patients with pancreatic cancer by earlier identification.
    Greenhalf W; Neoptolemos JP
    Nat Clin Pract Oncol; 2006 Jul; 3(7):346-7. PubMed ID: 16826198
    [No Abstract]   [Full Text] [Related]  

  • 27. Early Detection of Sporadic Pancreatic Ductal Adenocarcinoma: Problems, Promise, and Prospects.
    Chari ST; Sharma A; Maitra A
    Ann Intern Med; 2020 Apr; 172(8):558-559. PubMed ID: 32176886
    [No Abstract]   [Full Text] [Related]  

  • 28. Pancreatic cancer.
    Siriwardena AK; Siriwardena AM
    BMJ; 2014 Oct; 349():g6385. PubMed ID: 25361852
    [No Abstract]   [Full Text] [Related]  

  • 29. A pancreatic cancer multidisciplinary clinic: insights and outcomes.
    Schiffman SC; Abberbock S; Winters S; Valko C; Steve J; Zureikat AH; Zeh HJ; Hogg ME
    J Surg Res; 2016 May; 202(2):246-52. PubMed ID: 27229097
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical decision making in the management of pancreatic cystic neoplasms.
    Atiq M; Suzuki R; Khan AS; Krishna SG; Ridgway TM; Guha S; Hernandez LV; Nealon WH; Lee JH; Bhutani MS
    Expert Rev Gastroenterol Hepatol; 2013 May; 7(4):353-60. PubMed ID: 23639093
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Borderline resectable pancreatic cancer: rationale for multidisciplinary treatment.
    Takahashi S; Kinoshita T; Konishi M; Gotohda N; Kato Y; Kinoshita T; Kobayashi T; Mitsunaga S; Nakachi K; Ikeda M
    J Hepatobiliary Pancreat Sci; 2011 Jul; 18(4):567-74. PubMed ID: 21331805
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prognostic impact of preoperative NLR and CA19-9 in pancreatic cancer.
    Asaoka T; Miyamoto A; Maeda S; Tsujie M; Hama N; Yamamoto K; Miyake M; Haraguchi N; Nishikawa K; Hirao M; Ikeda M; Sekimoto M; Nakamori S
    Pancreatology; 2016; 16(3):434-40. PubMed ID: 26852169
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Surgical Aspects of Intraductal Papillary Mucinous Neoplasms of the Pancreas.
    Oláh A; Kollár D
    Chirurgia (Bucur); 2015; 110(5):413-7. PubMed ID: 26531783
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MicroRNAs: novel diagnostic and therapeutic tools for pancreatic ductal adenocarcinoma?
    Mardin WA; Mees ST
    Ann Surg Oncol; 2009 Nov; 16(11):3183-9. PubMed ID: 19636633
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Precursors of pancreatic cancer.
    Frič P; Škrha J; Šedo A; Bušek P; Laclav M; Bunganič B; Zavoral M
    Eur J Gastroenterol Hepatol; 2017 Mar; 29(3):e13-e18. PubMed ID: 28009716
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Current status of gene expression profiling of pancreatic cancer.
    Goonetilleke KS; Siriwardena AK
    Int J Surg; 2008 Feb; 6(1):81-3. PubMed ID: 18359465
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long-term clinical and imaging follow-up of nonoperated branch duct form of intraductal papillary mucinous neoplasms of the pancreas.
    Arlix A; Bournet B; Otal P; Canevet G; Thevenot A; Kirzin S; Carrere N; Suc B; Moreau J; Escourrou J; Buscail L
    Pancreas; 2012 Mar; 41(2):295-301. PubMed ID: 21946814
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Solid pancreatic tumors in patients younger than 40 years old--experience of a French comprehensive cancer center.
    Gilabert M; Turrini O; Niccoli P; Moureau-Zabotto L; Boher JM; Poizat F; Giovannini M; Delpero JR; Raoul JL
    Pancreas; 2015 Mar; 44(2):345-6. PubMed ID: 25675423
    [No Abstract]   [Full Text] [Related]  

  • 39. Toward a better understanding of pancreatic ductal adenocarcinoma: glimmers of hope?
    Partensky C
    Pancreas; 2013 Jul; 42(5):729-39. PubMed ID: 23648843
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Major molecular markers in pancreatic ductal adenocarcinoma and their roles in screening, diagnosis, prognosis, and treatment.
    Singh P; Srinivasan R; Wig JD
    Pancreas; 2011 Jul; 40(5):644-52. PubMed ID: 21673535
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.